Study Notes: Cardiotoxic Drugs of Abuse (Cocaine & Others)

Cocaine and Cardiotoxicity

• Mechanisms of toxicity

  • Blocks sodium ion channels → life-threatening dysrhythmias

  • Direct myocardial toxicity → acute myocarditis, long-term cardiomyopathy, stress-induced (Takotsubo) cardiomyopathy

  • Causes aortic dissections (~2% of cases in IRAD registry linked to cocaine)

  • Associated with acute myocardial infarction (MI)

• Pathophysiology of Cocaine-Induced MI

  • Coronary artery vasospasm (demonstrated in cath lab studies)

  • Increased myocardial oxygen demand (↑ BP, ↑ afterload, ↑ HR, ↑ contractility)

  • Hypercoagulable state (platelet activation, increased clot formation)

  • Accelerates atherosclerosis (chronic use → vascular injury, plaque formation)

Clinical Presentations

• Chest pain is the most common ED presentation

  • Sometimes due to true ACS (MI risk ~5%)

  • Sometimes due to cocaine’s direct sympathomimetic effects (non-ischemic chest discomfort)

• Two Patient Profiles

  1. Patient #1: The “Party Boy”

     • Young, healthy, first-time or infrequent user

     • Lower risk of underlying CAD

     • Still at risk for acute ACS from vasospasm/demand mismatch

     • Reasonable to discharge after: 2 negative troponins, normal EKGs, resolved pain, stable vitals

     • Stress testing usually unnecessary

  2. Patient #2: The “Old Pro”

     • Middle-aged, chronic user with decades of use

     • High risk of underlying CAD and accelerated atherosclerosis

     • Should be admitted/observed overnight with serial troponins, EKGs, possible further testing (stress test, stress echo, CT coronary angio)

ED Workup

• Standard chest pain workup: Hx, physical, EKG, CXR, troponins

• Differences from typical chest pain:

  • Always check cardiac markers in young cocaine users (even if otherwise low-risk)

  • Consider repeat troponin + repeat EKG

• Disposition

  • Young, first-time users with negative repeat markers → safe for discharge

  • Chronic users → higher risk, admit or observe with serial testing

• Guidelines

  • AHA 2008: Admit all cocaine chest pain patients for observation + serial troponins, EKGs, stress testing

  • Current practice: more selective; risk-stratify instead of blanket admission

• Risk Scoring

  • HEART score not reliable (does not account for cocaine use as a risk factor)

  • Low HEART score in cocaine users still → ~14% MACE (vs. 4% in non-users)

  • High-sensitivity troponins may improve early rule-out, but role still unclear

Treatment

• First-line basics

  • Aspirin: addresses platelet activation/hypercoagulability

  • Benzodiazepines (cornerstone): reduce sympathetic surge, HR, BP, agitation

    • Diazepam or lorazepam; titrate to effect (may require high doses)

  • Nitroglycerin: reduces vasospasm, pain, BP

  • Both benzos and nitrates effective—decide “sauce vs. spice” based on patient’s main presentation (e.g., agitation → benzos first; hypertension/CAD → nitrates first)

• Second-line / adjuncts

  • Morphine: reduces pain, vasospasm (watch for oversedation with benzos)

  • Non-DHP Calcium channel blockers (diltiazem, verapamil): reduce HR, BP, vasospasm

  • Phentolamine (pure α-blocker): treats refractory hypertension/vasospasm; rarely first-line but very effective

• Beta Blockers

  • Controversial → risk of “unopposed α-stimulation” (↑ vasospasm, ↑ BP)

  • Evidence: no clear proof of harm, but no strong evidence of safety/benefit either

  • Labetalol (α + β activity) studied → safe, but β > α effect

  • Bottom line: Avoid routinely; other meds available; if used, labetalol preferred

Key Takeaways

• Cocaine cardiotoxicity is multifactorial: vasospasm, ↑ demand, ↑ coagulability, and accelerated atherosclerosis.

• ~5% of cocaine chest pain patients have true MI; higher in chronic users.

• Distinguish young, first-time users (often safe to discharge after negative workup) vs. older, chronic users (admit/observe).

• Treatment cornerstones: benzodiazepines + aspirin + nitrates; avoid routine β-blockers.

• Risk stratification tools (e.g., HEART score) underestimate risk in cocaine patients.